These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27749097)

  • 21. The influence of interferon β-1b on gut microbiota composition in patients with multiple sclerosis.
    Castillo-Álvarez F; Pérez-Matute P; Oteo JA; Marzo-Sola ME
    Neurologia (Engl Ed); 2021 Sep; 36(7):495-503. PubMed ID: 34537163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arthritis during interferon beta-1b treatment in multiple sclerosis.
    Altintas A; Alici Y; Melikoğlu M; Siva A
    Mult Scler; 2002 Dec; 8(6):534-6. PubMed ID: 12474998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
    Tamura S; Warabi Y; Matsubara S
    J Clin Pharm Ther; 2012 Dec; 37(6):724-5. PubMed ID: 22642738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transvaginal sonography of the postmenopausal endometrium].
    Curcić A; Segedi D; Belopavlović Z; Petrović D
    Med Pregl; 2000; 53(1-2):59-63. PubMed ID: 10953553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations for postmenopausal uterine bleeding: special considerations for endometrial volume.
    Cho HJ; Lee ES; Lee JY; Hong SN; Ji YI; Kim HY; Kim A
    Arch Iran Med; 2013 Nov; 16(11):665-70. PubMed ID: 24206410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-related differential diagnosis of vaginal bleeding in postmenopausal women: a series of 3047 symptomatic postmenopausal women.
    Burbos N; Musonda P; Giarenis I; Shiner AM; Giamougiannis P; Morris E; Nieto JJ
    Menopause Int; 2010 Mar; 16(1):5-8. PubMed ID: 20424279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultra-low-dose continuous combined estradiol and norethisterone acetate: improved bleeding profile in postmenopausal women.
    Sturdee DW; Archer DF; Rakov V; Lang E;
    Climacteric; 2008 Feb; 11(1):63-73. PubMed ID: 18202966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The diagnostic value of hysteroscopy on postmenopausal bleeding].
    Gao X; Wu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):446-8. PubMed ID: 11387966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.
    Montalban X; Sastre-Garriga J; Tintoré M; Brieva L; Aymerich FX; Río J; Porcel J; Borràs C; Nos C; Rovira A
    Mult Scler; 2009 Oct; 15(10):1195-205. PubMed ID: 19797261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon beta for multiple sclerosis.
    Connelly JF
    Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenal carcinoma presenting with postmenopausal vaginal bleeding.
    Singer F
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):569-70. PubMed ID: 1870827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis, interferon beta-1b and depression A prospective investigation.
    Feinstein A; O'Connor P; Feinstein K
    J Neurol; 2002 Jul; 249(7):815-20. PubMed ID: 12140662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis.
    Menzin J; Caon C; Nichols C; White LA; Friedman M; Pill MW
    J Manag Care Pharm; 2013; 19(1 Suppl A):S24-40. PubMed ID: 23383731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of continuous and sequential transdermal progestogen with sequential oral progestogen in postmenopausal women using continuous transdermal estrogen: vasomotor symptoms, bleeding patterns, and serum lipids.
    Rozenberg S; Ylikorkala O; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():376-87. PubMed ID: 9397385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Postmenopausal uterine bleeding. Analytic study about 65 cases].
    Youssef A; Ben Aissia N; Gara MF
    Tunis Med; 2005 Aug; 83(8):453-6. PubMed ID: 16238271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women.
    Limpaphayom KK; Bunyavejchevin S
    J Med Assoc Thai; 2000 Apr; 83(4):407-16. PubMed ID: 10808701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension.
    Sriprasert I; Beydoun H; Barnabei V; Nassir R; LaCroix AZ; Archer DF
    Menopause; 2015 Oct; 22(10):1067-75. PubMed ID: 25756697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.